Longboard Pharmaceuticals, Inc.
LBPHDelisted Dec 2, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001832168
Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.
13F holders, Q4 2024
Institutional positions in Longboard Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
LBPH is no longer listed, and 13F filings after Q3 2024 list far fewer holders. See Q3 2024
- Institutional holders
- 0
- −124 vs. Q3 2024
- Shares held
- 0
- −39.8M (−100.0%) vs. Q3 2024
- Total value
- $0
- −$1.33B (−100.0%) vs. Q3 2024
- New holders
- 0
- 0 more added
- Sold out
- 124
- 0 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LBPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 125 | $1.33B |
| Q2 2024 | 100 | $1.05B |
| Q1 2024 | 105 | $819.5M |
| Q4 2023 | 52 | $99.7M |
| Q3 2023 | 51 | $87.1M |
| Q2 2023 | 50 | $106.7M |
| Q1 2023 | 25 | $51.5M |
| Q4 2022 | 18 | $23.3M |
| Q3 2022 | 19 | $27.0M |
| Q2 2022 | 20 | $23.3M |
| Q1 2022 | 21 | $40.1M |
| Q4 2021 | 21 | $37.8M |
| Q3 2021 | 20 | $68.2M |
| Q2 2021 | 17 | $71.7M |
| Q1 2021 | 22 | $142.8M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Longboard Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 0 | $0 | 0.00% | −3,625−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −3,168−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −1,954−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,813−100.0% | Sold out |
| Public Employees Retirement Association of Colorado | 0 | $0 | 0.00% | −1,490−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,332−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −1,274−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,039−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −841−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −550−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −473−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −193−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −142−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −128−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −104−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Sterling Capital Management LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Raymond James & Associates | – | – | – | – | Not filed |